secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-10-13T21:10:14+00:00
Accession:  0001213900-26-109087
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Tessera issues ~3.5M shares for MEA stake and DFSL warrant exercise; ATM raises over $6M
--------------------------------------------------------------------------------

- Issued 195,000 restricted shares to Mayers Ventures LLC for an equity interest in M.E.A. Testing Systems Ltd. plus an option on Motomova Inc.'s remaining MEA stake.
- Issued 3,278,039 restricted shares to Mandragola Ltd. in three cashless exercises of the DFSL Warrant from the April 13, 2026 buy of 60% of Dr. Frucht Systems Ltd.
- Shares outstanding 13,983,094 as of Oct 12, 2026, after these issuances and ATM sales; warrant has a $0.10 floor and 9.99% beneficial-ownership blocker.
- At-the-market program raised more than $6 million net at an average net price of about $1.11, as adjusted for the one-for-ten reverse split effective Sept 9, 2026.
- Management said it may temporarily halt ATM sales depending on market conditions; CEO Michael Oster signed the report Oct 13, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026109087/0001213900-26-109087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026109087/ea0308468-8k_tessera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-109087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer